216 related articles for article (PubMed ID: 33928470)
1. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
[TBL] [Abstract][Full Text] [Related]
2. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
Merki-Feld GS; Caveng N; Speiermann G; MacGregor EA
J Headache Pain; 2020 Jun; 21(1):81. PubMed ID: 32580694
[TBL] [Abstract][Full Text] [Related]
3. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
4. Impact of family history for endometriosis, migraine, depression and early menopause on endometriosis symptoms, localization and stage: A case control study.
Metzler JM; Imesch P; Dietrich H; Knobel C; Portmann L; Neumeier MS; Merki-Feld GS
Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():36-43. PubMed ID: 38103542
[TBL] [Abstract][Full Text] [Related]
5. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
6. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
7. Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk.
Batur P; Yao M; Bucklan J; Soni P; Suneja A; Farrell R; Mays M
Headache; 2023 Jun; 63(6):813-821. PubMed ID: 36752588
[TBL] [Abstract][Full Text] [Related]
8. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?
Tiranini L; Cucinella L; Martella S; Bosoni D; Martini E; Nappi RE
Expert Rev Neurother; 2023 Apr; 23(4):377-388. PubMed ID: 37038655
[TBL] [Abstract][Full Text] [Related]
9. Sex hormones and headache.
Silberstein SD; Merriam GR
J Pain Symptom Manage; 1993 Feb; 8(2):98-114. PubMed ID: 8492007
[TBL] [Abstract][Full Text] [Related]
10. Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study.
Vitali-Silva A; Vuolo IG; Gonzalez LH; Galvão RF; Farges SG; Bello VA; Poli-Frederico RC
Ir J Med Sci; 2023 Oct; 192(5):2203-2208. PubMed ID: 36720786
[TBL] [Abstract][Full Text] [Related]
11. Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
Nappi RE; Tiranini L; Bosoni D; Cucinella L; Piccinino M; Cumetti A; Perone V; Benedetto C
Gynecol Endocrinol; 2023 Dec; 39(1):2189971. PubMed ID: 36918022
[TBL] [Abstract][Full Text] [Related]
12. Menstrual Migraines: Diagnosis, Evidence, and Treatment.
Olson AK; Hansen KA
S D Med; 2021 Dec; 74(12):570-575. PubMed ID: 35015948
[TBL] [Abstract][Full Text] [Related]
13. Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.
De Icco R; Cucinella L; De Paoli I; Martella S; Sances G; Bitetto V; Sandrini G; Nappi G; Tassorelli C; Nappi RE
J Headache Pain; 2016 Dec; 17(1):70. PubMed ID: 27488685
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
15. Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception.
Craig AD; Steinauer J; Kuppermann M; Schmittdiel JA; Dehlendorf C
Contraception; 2019 Feb; 99(2):104-110. PubMed ID: 30227121
[TBL] [Abstract][Full Text] [Related]
16. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
17. The use of triptans in the management of menstrual migraine.
Mannix LK; Files JA
CNS Drugs; 2005; 19(11):951-72. PubMed ID: 16268666
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea.
Pasquini B; Seravalli V; Vannuccini S; La Torre F; Geppetti P; Iannone L; Benemei S; Petraglia F
Reprod Biomed Online; 2023 Jul; 47(1):71-76. PubMed ID: 37202318
[TBL] [Abstract][Full Text] [Related]
19. Medical contraindications in women seeking combined hormonal contraception.
Xu H; Eisenberg DL; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2014 Mar; 210(3):210.e1-5. PubMed ID: 24246525
[TBL] [Abstract][Full Text] [Related]
20. Burden of migraine related to menses: results from the AMPP study.
Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
